trending Market Intelligence /marketintelligence/en/news-insights/trending/FurGnEpeRhLkpwUX7DNEUw2 content esgSubNav
In This List

Skyline Medical to acquire up to 25% stake in Helomics

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Skyline Medical to acquire up to 25% stake in Helomics

Skyline Medical Inc. agreed to acquire up to 25% of Helomics Corp., a precision diagnostic company and integrated clinical contract research organization.

Skyline Medical is purchasing preferred stock convertible into 20% of the outstanding Helomics common shares, in exchange for total consideration of 1.1 million newly issued Skyline common shares. Skyline also has the right to convert a previous $500,000 loan to Helomics into an additional 5% equity stake, bringing the total ownership to 25%.

The completion of the purchase is subject to listing of the shares on Nasdaq.

The companies are currently in discussions to form a joint venture.